SUMMARY Respiratory tract involvement is common in adults with systemic lupus erythematosus (SLE). Although SLE in children usually follows a more severe course than in adults, there are few reports on pulmonary disease and lung function in children with SLE. We performed lung function tests and chest x ray examinations in eight children with SLE (mean age 11-1 years), three of whom presented with pulmonary symptoms. A high prevalence of lung involvement was found, including interstitial or localised infiltrations, pleural effusion, a restrictive impairment of lung function, and dysfunction of the diaphragm. Three patients required artificial ventilation. Two main mechanisms of ventilatory impairment seem to occur in children with SLE: firstly, acute interstitial pneumonia, which rapidly improves on treatment with steroids, and, secondly, restriction of lung volume, mainly due to respiratory muscle weakness.
Systemic lupus erythematosus (SLE) is charac-
terised by the production of auto-antibodies that damage multiple organ systems. Respiratory tract abnormalities are frequently observed in adult patients with SLE. The most common findings are sterile pleural effusion and pneumonia, which is usually due to infection. [1] [2] [3] [4] [5] [6] [7] Interstitial lung disease is found in only 3% of adult patients with SLE. ' Lung function studies in adults, however, have revealed a high incidence of abnormalities even in the absence of clinically apparent lung disease.2 Volume restriction, decreased compliance, reduced diffusion capacity, and hyperventilation with arterial hypoxia at rest or during exercise have been reported.2-6 In adult patients with SLE the degree of lung function impairment correlated poorly with clinical and x ray findings.4 Lung function seemed to be the most sensitive indicator of pulmonary involvement.4 SLE is uncommon in children aged 15 years or younger. When SLE does occur in this age group it often seems to follow a more severe course than in adults.7 8 Pleural and pulmonary involvement have been reported in up to 70% of paediatric patients with SLE, pleural effusion being the most common finding.9-11 There are few data on lung function in children with SLE: Singsen and Platzker found restrictive defects in seven (35%) and diffusion impairment in five (25%) of 20 patients with SLE (mean age 15-5 years) without clinical or radiological evidence of pulmonary disease.'"
We have diagnosed SLE in eight children aged 6-14 years in the Sophia Children's Hospital since 1980. In some of these patients pulmonary involvement was a prominent feature early in the course of the disease. We therefore examined all the cases for the presence and extent of respiratory tract involvement. Four patients were followed for two to three years. 
Methods

Results
The presenting symptoms were pulmonary shadows (cases 2, 6, and 8), with respiratory insufficiency (case 8), nephritis (case 4), arthritis (case 3), and general malaise, fever, and arthralgia (cases 1, 5, and 7).
Clinical and laboratory data are summarised in Table 1 . All patients eventually developed nephritis, Semistatic compliance measurements were abnormal in three patients (below 80% predicted). In all six subjects in whom it was measured Dco was diminished for body surface area but normal or increased for the remaining lung volume. In two subjects with a restriction in lung capacity (cases 2 and 5) and one with normal lung function at that time (case 8) we measured transdiaphragmatic pressures at 0% and 30% of vital capacity (Fig. 2 (Fig. 3) . Most subjects had one or more relapses of SLE after tapering the treatment with steroids. Six patients were eventually given azathioprine (2-4 mg/kg/day) because of steroid toxicity or frequent relapses with progression to renal insufficiency. Three patients showed a gradual improvement in vital capacity over several years, which was unaffected by changes in the activity of group.bmj.com on October 14, 2017 -Published by http://adc.bmj.com/ Downloaded from SLE. A stable restriction was present in case 2, which was not influenced by SLE relapses. In case 8 we measured lung function before SLE was diagnosed. She was initially referred because of fatigue and had no other symptoms suggestive of SLE. At that time no abnormalities in lung function were detected. A few months later she developed the acute severe interstitial pneumonia that led to the diagnosis of SLE. She required artificial ventilation for two weeks and improved dramatically after the beginning of treatment with steroids. One week after the artificial ventilation was stopped the lung function measurements were repeated and indicated a mild restriction, which improved slowly in the following years (Fig. 3) .
Blood gases, determined in arterialised capillary blood samples, were normal in all the patients except during acute episodes of respiratory insufficiency in cases 1, 4, and 8. Case 1 developed a progressive interstitial pneumonia and needed artificial ventilation with high airway pressures and oxygen for one month. She then died due to massive gastrointestinal blood loss. Autopsy showed a widespread necrotising vasculitis affecting all organ systems. The lungs showed interstitial inflammation and a diffuse haemorrhagic tracheobronchitis. Case 4, who was on haemodialysis, required ventilatory support several times because of acute pulmonary oedema. This was probably due to fluid overload. This patient died three years after diagnosis from pulmonary oedema, seizures, and cardiac arrythmia.
Discussion
Our findings suggest a high prevalence of lung disease in childhood SLE. The most common findings were pleural effusion and volume restriction; three of our patients presented with severe respiratory symptoms.
Interstitial lung disease, which is infrequently seen in adults with SLE, 1 was present on x ray examination in three and was histologically confirmed in one of our eight patients. Treatment with steroids seemed to be clinically effective in two of these subjects (cases 2 and 8). The normal diffusion capacity when corrected for lung volume in case 8 suggested that no important interstitial disease had remained. A considerable restriction of vital capacity persisted, however, in case 2 and was also found in three patients without radiological signs of interstitial disease and normal diffusion capacity (cases 4, 5, and 6). Martens Dysfunction of the diaphragm and other respiratory muscles in adult patients with SLE, which may be due to myopathy, has been reported recently. 1820 We found markedly decreased transdiaphragmatic pressures in two patients who had restriction in lung volumes (cases 2 and 5). One of these patients (case 2) had clinical and electromyographic signs of myopathy in other muscles. This suggests that the respiratory muscle strength was impaired due to myopathy. The decreased compliance in three patients, two of whom had no radiological signs of interstitial lung disease, might have been caused mainly by muscle weakness with diminished inflation of normal lung tissue and not by interstitial fibrosis and inflammation. This possibility has been suggested by Martens et al, who found normalisation of the compliance after passive lung inflation to normal volume in adult patients with SLE. 18 For technical reasons, this could not be performed in our patients. Multiple small atelectases, which have been described in lungs from adult patients with SLE, might also have contributed to an increased lung stiffness and a restriction in lung volume. Maximal expiratory flows were low in four patients. Normal values were obtained, however, after correction for total lung capacity. Together with the normal shape of the flow-volume loops, this makes airway obstruction unlikely.
Localised pulmonary shadows were present in three patients. Although we cannot exclude that this may have been due to infection, this seems unlikely because initially no micro-organisms were cultured from the sputum, which was usually scanty and clear. Furthermore, treatment with antibiotics was always ineffective, and these pulmonary shadows resolved during treatment with steroids. Secondary infection was only documented in case 1, who deteriorated despite maximal therapeutic efforts.
The severity of lung disease was not related to the overall activity of the disease. Several patients experienced relapses and, for instance, developed rapidly progressive glomerulonephritis without a decrease in lung function. Furthermore, in three of the four patients we followed the lung function improved gradually regardless of SLE relapses. This contrasts with the course of the renal disease in SLE, which tends to progress to renal failure despite treatment.
In conclusion, we have found a high prevalence of disease of the respiratory tract in childhood SLE. Our findings suggest that there are two main reasons for the impairment in lung function in these children. The first is interstitial pneumonia, which follows an acute course and improves on treatment with steroids. The second is respiratory muscle weakness, which is not particularly disabling and can persist for years.
